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Hiccup: Mystery, Nature and Treatment
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of Medicine, Taipei, Taiwan
Hiccup is the sudden onset of erratic diaphragmatic and intercostal muscle contraction and immediately followed by laryngeal 
closure. The abrupt air rush into lungs elicits a “hic” sound. Hiccup is usually a self-limited disorder; however, when it is pro-
longed beyond 48 hours, it is considered persistent whereas episodes longer than 2 months are called intractable. A reflex arc 
involving peripheral phrenic, vagal and sympathetic pathways and central midbrain modulation is likely responsible for hiccup. 
Accordingly, any irritant in terms of physical/chemical factors, inflammation, neoplasia invading the arc leads to hiccups. The 
central causes of hiccup include stroke, space occupying lesions and injury etc, whereas peripheral causes include lesions along 
the arc such as tumors, myocardial ischemia, herpes infection, gastroesophageal reflux disease and applied instrumentations 
on human body etc. Besides, various drugs (eg, anti-parkinsonism drugs, anesthetic agents, steroids and chemotherapies etc) 
are the possible etiology. An effective treatment of persistent hiccup may be established upon the correct diagnosis of lesion 
responsible for the serious event. The pharmacotherapy of hiccup includes chlorpromazine, gabapentin, baclofen, serotonergic 
agonists, prokinetics and lidocaine. Non-pharmacological approaches such as nerve blockade, pacing, acupuncture and meas-
ures to hold breathing are also successful. Finally, alternative medicines and remedies are convenient to treat hiccups with un-
certain effect. In conclusions, hiccup is likely to result from lesions involving the hiccup reflex arc. The lesion may need to be 
localized correctly for ablative treatment in patients with intractable hiccup. Apart from lesion ablation, drugs acting on reflex 
arc may be effective, while some other conventional measures may also be tried.
(J Neurogastroenterol Motil 2012;18:123-130)
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Introduction
Both functional belching and hiccup are abnormal physio-
logical behavior activated by the air movement. Functional belch-
ing results from venting of excessive gas from stomach and it is 
often accompanied with gastroesophageal reflux disease (GERD).
1 
It belongs to one of the functional gastrointestinal disorders. In 
contrast, hiccup is the sudden onset of erratic diaphragmatic and 
intercostal muscular myoclonus which are followed immediately 
by laryngeal closure, hence the abrupt air rush into lungs induces 
the vocal cords to close leading to a “hic” sound.
2,3 Hiccup or sin-
gultus is derived from the Latin word singult, which means “the 
act of catching one’s breath while sobbing.”
4
Hiccup occurrence is not only confined to the adults but also 
observed among the infants
5,6 and children.
7 It is usually a 
self-limited disorder meaning many episodes would subside 
spontaneously without any clinical significance. The self-limited Full-Young Chang and Ching-Liang Lu
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Figure. The putative hiccup reflex arc. It includes afferent limb to 
receive stimulation either located in the central nervous system or from 
peripheral lesions, central brain processing and efferent limb to convey 
responded signals to the diaphragm and respiratory muscles. Adapted 
from Takahashi et al.
11
hiccup is believed to be induced by the rapid stomach distension 
and irritation in terms of overeating, eating too fast, ingesting spi-
cy food, drinking carbonated drinks, aerophagia and sudden 
change in ingested food temperature (eg, hot or cold drinks, a 
cold water shower, using alcohol and excessive smoking etc).
8 
Persistent hiccup means episode lasting for 48 hours or more, 
whereas those longer than 2 months are considered intractable.
2,9 
Severe and prolonged hiccup may lead to exhaustion, fatigue, 
malnutrition, weight loss, dehydration and even death in the ex-
treme situations.
8,9 Since hiccup has a neurological reflex arc con-
sisting of peripheral pathways and central midbrain modulation, 
patients with intractable hiccups are likely to have structural or 
functional irritation involving the reflex arc.
2,3,9
Unfortunately, there is no guideline available to direct treat-
ing this serious disorders effectively. Chlorpromazine is approved 
by the US Food and Drug Administration as the only drug to 
treat hiccup until now.
2 However, using chlorpromazine to treat 
hiccup without correct diagnosis of lesion responsible for hiccup 
may lead to missing potentially serious conditions that may cause 
this symptom. Literature suggests that measures ranging from 
conventional remedies, alternative medicines to emerging thera-
pies may treat hiccups successfully.
2 The authors attempt to re-
view current understanding of pathophysiology and management 
of hiccup.
Pathophysiology
The pathophysiological mechanism of hiccup is related to le-
sions in its reflex arc shown in Figure. The hiccup reflex arc con-
sists of 3 components, the afferent limb including phrenic, vagus 
and sympathetic nerves to convey somatic and visceral sensory 
signals, the central processing unit in the midbrain and the effer-
ent limb traveling in motor fibers of phrenic nerves to diaphragm 
and accessory nerves to the intercostal muscles, respectively.
2,10,11 
Central process of hiccup remains poorly understood, it may not 
only be confined to the medulla but may also involve other parts 
of central nervous system (CNS) located between brainstem and 
cervical spine.
2 The hiccup central component usually refers to 
chemoreceptors probably located in the peri-aqueductal gray 
matter and sub-thalamic nuclei.
10 Among the neurotransmitters 
involved in the process of hiccup, both dopamine (D) and gam-
ma-aminobutyric acid (GABA) have been documented.
2 The 
above pathophysiological basis explains why some inhibitors of 
these substances may be employed in treatment of hiccup. 
Accordingly, any physical and chemicals irritants and in-
flammatory and neoplastic conditions involving the hiccup reflex 
may cause hiccup. In addition, hiccup may be transient in many 
patients as spontaneous resolution of the stimuli that caused it 
might lead to its disappearance.
8 Unfortunately, owing to the 
long trajectory of afferent and efferent nerves and the diffuse cen-
tral processes involving the hiccup reflex arc, the accurate diag-
nosis of lesions in the arc and trying to terminate the pathological 
processes in the intractable events are often very difficult.
8 As sev-
eral types of lesion located along the hiccup reflex arc may cause 
it, hiccup is common and has been described as case reports in as-
sociation with several conditions and has been treated with vari-
ous types of treatment, which might confuse readers.
Etiology of Persistent and 
Intractable Hiccups
In the review of recent literature, too many causes of hiccups 
have been reported. Some are well known to invade the hiccup re-
flex arc, whereas many others remain unexplained why they 
would elicit persistent or intractable hiccups since no obvious in-
vasion to the hiccup reflex pathway was confirmed. According to 
the sites of lesion, hiccup may originate either from central or pe-
ripheral pathways. Briefly, Table 1 summarizes the reported eti-
ology of persistent and intractable hiccups. Their details are fur-
ther illustrated in the following.
Cerebral Vascular Accidents
Brain ischemia or stroke is not rare among the individuals 
with intractable hiccup and in some patients cerebrovascular 
cause was correctly diagnosed months later.
11-13 If a correct diag-
nosis is made, intractable hiccup may resolve after initiation of an-
ticoagulant therapy.
14 In addition, hiccup did occur in the patient Hiccup
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Table. Reported Etiology of Persistent and Intractable Hiccups
Lesion site/Type Disease/Disorder
Central nervous system
    Vascular disease Stroke, infarct, systemic lupus erythematosus related vascular disorders and aneurysms
    Tumor Astrocytoma, carvenoma and brain stem tumors
    Inflammation Neuromyelitis optica and multiple sclerosis
    Trauma Brain injury
    Miscellaneous Seizure, cranial nervous herpes infection and parkinsonism 
Peripheral pathway
    Chest cavity Mediastinal diseases, lymphadenopathy and diaphragmatic tumors 
    Heart Myocardial ischemia
    Gastrointestinal tract Esophageal tumors, gastroesophageal reflux diseases, stomach volvulus and H. pylori infection
    Lower abdomen  Gynecologic tumors
    Miscellaneous Cancers
Procedure
    Surgery Anesthetic agents and post-operative disturbances
    Chemotherapy Chemotherapeutic agents and steroids
    Drugs Anti-parkinsonism treatment, psychiatric medications, azithromycin and morphine 
    Instrumentation Atrial pacing, catheter ablation, central venous catheterization, esophageal stent placement, bronchoscopy, tracheostomy
and shaving beards
Miscellaneous Electrolyte imbalance, ethanol users, tuberculosis and chronic renal failure
H. pylori, Helicobacter pylori.
with systemic lupus erythematosus related to medulla infarct, 
which was successfully treated with corticosteroid.
15 Steroid was 
also useful in a patient with systemic lupus erythematosus and 
hiccup related to vasogenic edema due to aseptic meningitis con-
firmed on imaging.
16 Briefly, clinicians should consider the prob-
ability of CNS ischemia/stroke among aged people or subjects 
with vascular disease presenting with persistent or intractable hic-
cup to avoid delay in diagnosis and initiation of ineffective 
treatment.
Central Nervous System Tumors, Injury and 
Inflammatory Diseases
There is no doubt that any space occupying lesion in the 
brain has the chance to elicit hiccup. The reported brain tumors 
to induce serious hiccups included astrocytoma, cavernoma and 
brain stem tumors etc.
17-19 Therefore, these hiccups usually re-
solved after surgical resection of the brain lesions.
17 Cerebellar ar-
tery aneurysm also reported to result in hiccup and that was effec-
tively treated after surgery.
20 Brain injury may cause intractable 
hiccup.
21 It is apparent that a carefully taken history regarding 
CNS is very important when we encounter these subjects with 
persistent or intractable hiccup. Apart from other brain stem 
symptoms like nausea and vomiting, neuromyelitis optica may 
cause intractable hiccup because this disease is an inflammatory 
disease involving optic nerves and spinal cord. It is indicated that 
half of them had brain stem symptoms, while prolonged hiccup 
occurred in 17%-66% of victims during the illness.
22,23 Hiccup is 
considered as one form of infant seizure related manifestations. 
Unfortunately, it persisted in spite of subsidence of other seizure 
symptoms.
5
Lesions Along the Peripheral Neuro-pathways
A patient with mediastinal lymph node sarcoidosis, which 
was likely the lesion invading the hiccup reflex arc, had persistent 
hiccup that did not respond to steroid therapy.
24 A tumor infiltra-
tion on the diaphragm was considered as the obvious cause of in-
tractable hiccup.
25 A patient with herpes zoster involving cranial 
nerve neurons including the vagus nerve presented with intract-
able hiccup and diaphragmatic paralysis; acyclovir treatment ef-
fectively ameliorated hiccup in this patient.
26 Hiccup has been an 
unrecognized symptom of esophageal cancer. In a large series of 
99 patients with esophageal tumors originating from any parts of 
esophagus, 27% had persistent hiccup longer than 48 hours.
27 
The hiccup might be either due to primary effect of tumor or sec-
ondary to dilatation of esophagus above the stenotic lesion asso-
ciated with raised intra-luminal pressure eliciting a reflex 
activity.
27 Hiccup was reported as a subtle sign of stomach volvu-
lus and was probably induced by the diaphragmatic irritation Full-Young Chang and Ching-Liang Lu
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from the distended stomach.
28 Interestingly, myocardial ischemia 
has been one of unusual reasons for intractable hiccups. For ex-
ample, some myocardiac ischemia-related intractable cases were 
effectively treated using either coronary intervention or acupunc-
ture.
29,30 Perhaps, the disorder is elicited by released factors from 
ischemic tissues with action on the hiccup arc or ischemic injury 
of the sensory branches in pleura, pericardium and peritoneum, 
which also send signal to the phrenic nerves.
29,30 Hence, my-
ocardial ischemia can also cause vagal and phrenic nerve irrita-
tion.
Gastrointestinal and Abdominal Disorders
It is well known that GERD is commonly associated with 
belching. Apart from the main reflux symptoms in terms of acid 
regurgitation, heartburn, globus, dysphagia and hoarseness etc, 
hiccup was not rare among the GERD patients.
31 Even it may be 
underestimated among the GERD patients, a case series in-
dicated that 7.9% male and 10% female (P ＜ 0.05) GERD pa-
tients had hiccup episodes.
32 In addition, acid infusion as a provo-
cative test did confirm the GERD related hiccup, while some 
prolonged hiccups also responded well to the proton pump 
inhibitors.
33,34 Since severe belching may sometime precede the 
hiccup episode, perhaps belching is the mechanism leading to 
hiccup among the GERD subjects.
35 It is also unbelievable that 
Helicobacter pylori infection was indicated as a cause of hiccup, 
which was confirmed via successful bacterial eradication. The pu-
tative pathogenesis might be related to increased acid production 
following H. pylori infection that might stimulate esophageal mu-
cosa irritating vagal afferents.
36
Anesthetic and Post-operative Hiccups
Post-operative hiccups were reported in subjects receiving 
various surgeries, for example, Whipple operation and colectomy. 
Of them, surgery related gastroparesis was suggested as one of 
the mechanisms leading to the hiccups.
8,37 On the other hand, us-
ing anesthetic agents in surgery may be associated with hiccups. 
For example, propofol induction during anesthesia induced 
hiccups.
38 Even an epidural anesthesia using bupivacaine led to 
repeated hiccup in a patient. The addressed mechanisms in-
cluded the interruption of inhibitory reflex of phrenic nerve mo-
tor drives and direct de-afferentation of visceral sensory pathway 
resulting in increased diaphragmatic activities and hiccups.
39,40 
An infant using epidural ropivacaine in a fistula surgery devel-
oped persistent hiccup in a dose dependent manner and it rapidly 
subsided in a low dose infusion.
6 Overall, it is uncertain whether 
some cases of post-operative hiccups are the effect of direct sur-
gery or secondary to anesthetic agents.
Hiccups in Patients With Cancer and on Che-
motherapy
Serious hiccup is not unusual among the cancer patients. For 
instance, an Italian report indicated that 3.9% in-patients and 
4.5% out-patients had severe chronic hiccup.
41 Among some pa-
tients with cancer, hiccup might be secondary to chemotherapy. 
A retrospective analysis pointed out that hiccups occurred among 
0.39% of chemotherapy treated patients including cisplatin, car-
boplatin and etoposide etc, particularly among males.
42 Cisplatin 
is often the offending agent inducing hiccup; the postulated 
mechanism includes initiation of an emetic reflex by releasing 
5-hydroxyltryptamine (HT) from the enterochromaffin cells and 
vagal afferents. Because vagus nerve is one of the afferents of hic-
cup reflex arc, using cisplatin often initiates hiccup reflex.
43 
Clinically, the occurrences of hiccups among the Japanese pa-
tients receiving various doses of cisplatin therapy ranged from 
6.1% to 10%.
44 Besides, a prospective trial conducted in Taiwan 
showed that hiccups developed among 41.2% patients using both 
combination of cisplatin and dexamethasone therapy, and 97.4% 
of the victims were male patients. Consequently, the authors sug-
gested that steroid could induce hiccup when combined with cis-
platin therapy synergistically because steroid receptors are likely 
to exist within the efferent limbs of hiccup reflex.
43 Similarly, hic-
cups did occur among various steroid users.
45,46 In some in-
stances, etiological relationship between steroid use and hiccup 
was established by discontinuation of steroid therapy, which ame-
liorated hiccup. Alternatively, steroid when combined with ramo-
setron could be effective in preventing the chemotherapy related 
hiccups.
47 In fact, steroid is listed as one of the recommended 
agents to treat hiccups.
8 Steroid may behave as two sides of a 
knife either by inducing serious hiccup or by preventing it when 
combined with some other drugs.
Other Drugs Inducing Hiccups
Twenty percent of parkinsonism (PD) patients had frequent 
hiccups compared to 3% of the controls. Even in some patients, 
PD was diagnosed after occurrence of intractable hiccups. 
Replacement therapy with dopamine agonists in PD patients is 
considered to induce certain episodes of hiccup; however, in oth-
ers, hiccup may occur as the non-motor symptom of PD rather 
than as side effect of anti-PD treatment.
48 The pathogenesis is 
believed to be related to the fact that dopamine agonists share a Hiccup
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high affinity for D3 receptors which may be involved in the hic-
cup reflex arc.
49 Hence, the drugs to block dopaminergic neuro-
transmission including chlorpromazine and metoclopramide may 
be employed in treating hiccup episodes.
48 Psychiatric medi-
cations may also induce hiccups. Aripiprazole, a partial agonist at 
the D2, D3 receptors and 5-HT1A receptors, is used to stabilize 
dopamine and serotonin systems through these receptors. A pa-
tient was confirmed to manifest hiccup after using this agent be-
cause discontinuation was followed by quick symptom resolution 
within hours.
50 Intractable hiccup also subsided after disconti-
nuation of oral azithromycin and intra-thecal morphine admini-
stration. It is hypothesized that azithromycin activates vagal 
mechanism leading to hiccup.
51 Regarding the latter case, the re-
placement of hydromorphone did not induce hiccup although 
both drugs almost shared the similar structure with little differ-
ence.
52 In summary, in patients with intractable hiccup, drug his-
tory should be carefully reviewed as discontinuation of offending 
drugs may dramatically resolve hiccup.
Instrumentation Related Hiccups
Interestingly, many measures on human body have been 
known to elicit serious hiccups. Of them, mechanical irritation of 
phrenic nerves via various measures is well-known. Because the 
right phrenic nerve is a branch of cervical plexus with close con-
tact to the right atrium, atrial pacing for brady-arrhythmia and 
catheter ablation for atrial fibrillation were reported to induce dia-
phragmatic contractions and hiccups.
53,54 Similar cardiovascular 
measures such as central venous catheter advancing up to the 
right ventricle also induced serious hiccups.
55 A patient with 
esophago-gastric junction tumor developed intractable hiccup af-
ter placing esophageal stent, which was likely related to irritation 
of afferents of hiccup reflux arc.
56 The procedures upon respira-
tory tract, for example, bronchoscopy and tracheostomy were also 
reported to cause serious hiccups.
7,57 Although the authors never 
addressed the possible mechanisms, they were similar to those 
with esophageal lesions and instrumentations. Healthy men shav-
ing or stroking their chins had triggered an acute explosive 
hiccup.
58 This might be explained by the fact that the sensory af-
ferents from chin convey signal to the intermediate part of spinal 
tract nucleus of fifth nerve, which also projects to the medullary 
reticular formation that interplay with the phrenic nucleus and 
nucleus ambiguous, which are involved in centrally mediated 
hiccup. Other miscellaneous causes of hiccup include electrolyte 
imbalance, tuberculosis infection, ethanol users and chronic renal 
failures etc.
59
Treatment of Hiccups
Basically, transient hiccups are self-limited, and neither etio-
logical evaluation nor immediate treatment is needed for these 
subjects unless their hiccup recurs. The effective hiccup treat-
ment is exactly established upon a correct diagnosis of lesion re-
sponsible for the serious event. For example, after effective meas-
ures were undertaken to CNS lesions such as vascular ischemia 
and tumors, hiccup episodes subsided. Similarly, some peripheral 
lesions related hiccups responded well after these lesions were 
ablated. In addition, many available therapies are not evi-
dence-based; moreover, alternative medicines and remedies have 
been tested with unbelievable effectiveness.
Drug Treatment
Apart from the well-known chlorpromazine approved to treat 
hiccups, many other drugs have been tested and recommended. 
For example, anticonvulsants in various preparations are in-
dicated to treat intractable hiccups. Gabapentin, an alpha-2-delta 
ligand with structural similarity to GABA and the ability to block 
voltage-operated calcium channels to reduce release of several 
neurotransmitters including glutamate and substance P and fi-
nally to modulate the diaphragmatic activity, was promising and 
safe to treat intractable hiccups.
25,41,60 Overall, the response rates 
of gabapentin ranged from 66.7% to 88.4%. Reported side effect 
of gabapentin is sleepiness.
41 Baclofen, a GABA derivative, has 
been used to treat hiccup due to CNS tumors and chronic renal 
failure.
19,59 However, baclofen should be used very cautiously in 
elderly subjects and those with renal failure because of the side ef-
fects such as nephrotoxicity, over sedation, ataxia and confu-
sion.
59,61 Carvedilol, a potent non-cardio selective beta-blocker, 
calcium channel blocker and antioxident used to treat tardive dys-
kinesia of chorea, was also tried in intractable hiccup effectively.
62 
Besides, 5-HT agonist, for example, tandospirone (affinity to 
5-HT1A) was also promising to treat stroke related hiccup be-
cause of direct inhibition of phrenic nerve activity via centrally lo-
cated receptors.
11 Olanzapine, a serotonergic antagonist with ac-
tion on post-synaptic receptors, was also used to diminish the 
phrenic motor neuron activity to treat hiccup of a brain injury 
case.
21 Midazolam, a benzodiazepine, acts on benzodiazepine re-
ceptors to form the benzodiazepine-GABA receptor-chloride 
ionophore complex in gating chloride channels which leads to hy-
perpolarization to inhibit neuron firing and to decrease neuronal 
depolarization. When combined with morphine, midazolam did 
control the intractable hiccup in a cancer patient.
63 Amantadine, Full-Young Chang and Ching-Liang Lu
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acting as a low-affinity antagonist at the N-methyl-D-aspartate 
subtype of glutamate receptors, has been used as anti-PD therapy 
because over-activity of glutamatergic transmission is one of 
mechanisms leading to PD; this agent was successfully used to 
treat postoperative hiccup in a cancer patient.
8 Traditionally, pro-
kinetics have been widely used to treat hiccups because stomach 
distension is considered as one of the mechanisms leading to 
hiccups.
64 In fact, premedicated metoclopramide treatment did 
effectively prevent the anesthesia induced hiccup.
65 Lidocaine 
can stabilize cell membrane by blocking sodium channels to re-
duce neuronal excitability. It has been used successfully in treat-
ing or pre-treating intractable hiccups induced via many 
measures.
57,66,67 Other miscellaneous agents used to treat hiccup 
include calcium channel blockers and antidepressants.
8
Non-pharmacological Measures to Treat Hic-
cups
Phrenic nerve blockades such as ultrasound guided blocking 
of efferent limbs, trans-esophageal diaphragmatic pacing and 
nerve stimulator to confirm the effective blocking were success-
fully used to treat persistent post-operative and lung cancer re-
lated hiccups.
37,40,68 Even a left vagal afferent blockade via nerve 
stimulation might be applied to stroke related intractable hiccup 
after failure of phrenic nerve block.
69 Ultrasound guided pulsed 
radiofrequency ablation of phrenic nerve was another option to 
treat coronary by-pass surgery related hiccup.
70 Acupuncture has 
been employed to treat serious hiccups among patients with my-
ocardial infarction and metastatic liver tumor.
30,71 A control trial 
confirmed that this procedure was superior over ritaline to treat 
stroke related hiccups.
12 The addressed mechanisms of acu-
puncture procedure are complex which include changed axonal 
excitability, diminished nociceptive circuits in the dorsal horn, in-
hibited spinal reflexes, segmental pre- and post-synaptic in-
hibition mediated by GABA, and activated supra-spinal centers 
via spinoreticular fibers, and spinothalamic and spinomesence-
phalic neurons etc.
71 Similarly, near-infrared irradiation applied 
on the acupoints to improve the local blood circulation of affected 
areas has been shown to effectively treat intractable hiccups.
13,72
Breath Holding and Folk Remedies to Treat 
Hiccups
Measures other than the recommended drugs and in-
strumentation have been used to treat hiccups safely. For exam-
ple, gag reflex has long been used as an immediate remedy to treat 
hiccup. The possible mechanism include restoration of normal 
phrenic nervous rhythms due to artificial and transient stoppage 
of respiration.
3 In one patient, an inflated cuff of laryngeal mask 
airway was used to stimulate the pharynx opposite second cervical 
vertebra to inhibit hiccup during induction with propofol.
38 
Unfortunately, this procedure was also a trigger to induce hic-
cups commonly among some subjects.
73 On the other hand, su-
pramaximal inspiration, a measure consisted of hypercapnia, dia-
phragm immobilization and positive airway pressure could termi-
nate intractable hiccups in pregnancy via holding diaphragm for 
more than 20 seconds.
74 As well as being used to expel aspirated 
water, debris and vomitus, modified Heimlich maneuver with 3 
thrusts delivered at 10 second interval could terminate hiccup im-
mediately with the suggested mechanism of stabilizing dia-
phragmatic spasm.
75 Intranasal vinegar instillation to stimulate 
the dorsal pharynx at the supplied area of afferent branches of 
hiccup reflex arc was effective in a child with tracheostomy re-
lated hiccup.
7 Finally, other remedies in terms of breathing into a 
bag, breath holding, swallowing granulated sugar, drink-
ing/gargling iced water, forceful traction of tongue, biting lemon, 
eating peanut butter, eyeball compression, carotid/rectal massage, 
Valsava maneuver, fright and gastric lavage etc have long been 
recommended to treat hiccups for many years. These remedies 
may be very convenient and less hazardous, however, their effec-
tiveness to treat serious hiccups are usually uncertain.
2,3,61
Conclusion
Hiccup usually results from a lesion involving the hiccup re-
flex arc. Among patients with persistent or intractable hiccup, at-
tempt to identify the lesion causing it is needed since serious or le-
thal disorder may exist. Apart from lesion ablation, drugs and 
measures acting on the reflex arc may be effective, while some 
conventional remedies can be tried while their effects to terminate 
hiccups are uncertain.
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